Exclusive

Publication

Byline

Location

US Patent Issued to KIMBALL WESTWARD on Aug. 18 for "Polyphenolic insulin" (Maryland Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,659, issued on Aug. 18, was assigned to KIMBALL WESTWARD LLC (Sheridan, Wyo.). "Polyphenolic insulin" was invented by Robert R. Reddy (Fred... Read More


US Patent Issued to THE BIOREGENTECH INSTITUTE on Aug. 18 for "Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods" (California Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,660, issued on Aug. 18, was assigned to THE BIOREGENTECH INSTITUTE INC. (Irvine, Calif.). "Therapeutic systems, devices, and compositions w... Read More


US Patent Issued to Ipsen Biopharm on Aug. 18 for "Treatment of brain damage" (British Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,661, issued on Aug. 18, was assigned to Ipsen Biopharm Ltd. (Wrexham, Great Britain). "Treatment of brain damage" was invented by Mikhail K... Read More


US Patent Issued to Oklahoma Medical Research Foundation on Aug. 18 for "Monoclonal antibody against human activated protein C and preparation and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,662, issued on Aug. 18, was assigned to Oklahoma Medical Research Foundation (Oklahoma City). "Monoclonal antibody against human activated ... Read More


US Patent Issued to VIVALDI BIOSCIENCES on Aug. 18 for "Influenza virus encoding a truncated NS1 protein and a SARS-CoV receptor binding domain" (Austrian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,663, issued on Aug. 18, was assigned to VIVALDI BIOSCIENCES INC. (Fort Collins, Colo.). "Influenza virus encoding a truncated NS1 protein a... Read More


US Patent Issued to argenx on Aug. 18 for "Methods of treating paraproteinemic neuropathy with anti-C2 antibodies" (Dutch, Belgian Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,664, issued on Aug. 18, was assigned to argenx BV (Ghent, Belgium). "Methods of treating paraproteinemic neuropathy with anti-C2 antibodies... Read More


US Patent Issued to Beth Israel Deaconess Medical Center on Aug. 18 for "Anti-IL-1Beta antibody therapy in arrhythmogenic cardiomyopathy (ACM)" (Massachusetts Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,665, issued on Aug. 18, was assigned to Beth Israel Deaconess Medical Center Inc. (Boston). "Anti-IL-1Beta antibody therapy in arrhythmogen... Read More


US Patent Issued to Regeneron Pharmaceuticals, Sanofi Biotechnology on Aug. 18 for "Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist" (New York, New Jersey, Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,666, issued on Aug. 18, was assigned to Regeneron Pharmaceuticals Inc and Sanofi Biotechnology (Paris). "Methods for treating allergy and e... Read More


US Patent Issued to The University of Chicago on Aug. 18 for "Compositions and methods concerning combinations of immunologic inhibitors for the treatment of cancer" (Illinois Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,667, issued on Aug. 18, was assigned to The University of Chicago (Chicago). "Compositions and methods concerning combinations of immunolog... Read More


US Patent Issued to Pfizer on Aug. 18 for "Stable aqueous anti-TFPI antibody formulation" (Massachusetts, Kansas Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,668, issued on Aug. 18, was assigned to Pfizer Inc. (New York). "Stable aqueous anti-TFPI antibody formulation" was invented by Thomas Jose... Read More